TORONTO, Sept. 5, 2023 /CNW/ - CareRx Corporation ("CareRx" or "the Company") (TSX: CRRX) today announced that the Toronto Stock Exchange (the "TSX") has approved the Company's previously announced normal course issuer bid (the "NCIB") to purchase for cancellation up to 1,000,000 of its common shares ("Shares"), representing approximately 1.73% of its 57,743,726 issued and outstanding Shares as at August 31, 2023.
Read more at newswire.caCareRx Corporation Receives Regulatory Approval for Launch of its Normal Course Issuer Bid
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.
